RxDoctor Payments Data

Satoshi Tateshima, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1922042068

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $484,500 of the $764,160 with a category attached, or 63.4%. Corindus Inc. accounts for 63.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $507,287 and has fallen 87.5% since, to $63,483 in 2025. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$764,160in general payments, 2019–2025

Across 284 payments — averaging $2690.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corindus Inc.$485K
  • Stryker$126K
  • Medical Device Business Services, Inc.$96K
  • Rapid Medical Ltd$33K
  • Medtronic$15K
  • Penumbra, Inc.$2K
  • plus $8K from 14 others
$141,532in research payments, 2019–2025

Across 22 payments — averaging $6433.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rapid Medical Ltd$105K
  • Medical Device Business Services, Inc.$14K
  • Medtronic$13K
  • Microvention, Inc.$8K
$20,403in ownership & investment interests, 2019–2025

Across 5 payments — averaging $4080.69 each. An ownership or investment interest held by the physician or an immediate family member.

  • Viseon, Inc.$20K
  • Neurovasc Technologies, Inc.$0

What the payments were for

  • Consulting fees$187,78225%
  • Speaking & faculty fees$5,9751%
  • Travel & lodging$76,30710%
  • Food & beverage$9,5961%
  • Ownership interest$484,50063%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corindus Inc.4$485,406
Stryker117$125,701
Medical Device Business Services, Inc.57$95,911
Rapid Medical Ltd22$32,798
Medtronic(2 entities)35$14,682
Penumbra, Inc.3$2,052
Nippon Boehringer Ingelheim Co., Ltd.1$1,500
Balt USA, LLC9$1,028
Canon Medical Systems USA, Inc.1$1,000
Johnson & Johnson11$934
Imperative Care, Inc2$828
Microvention, Inc.10$724
Depuy Synthes Products, Inc.2$602
Phenox Inc.4$427
MIVI Neuroscience, Inc.1$221
Asahi Intecc USA, Inc.1$136
Biosense Webster, Inc.1$104
Neurovasc Technologies, Inc.1$56
Siemens Medical Solutions USA, Inc.1$27
Biogen1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$764,160 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$57,314
Medicare patients
73
Services billed
251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →